Welcome to Apsida Insights, the podcast that takes you inside the world of life science. Hosted by the experts at Apsida Life Science, we bring you exclusive conversations with industry leaders, deep dives into market trends, and discuss career growth, hiring strategies, and international expansion.
From biotech breakthroughs to scaling a recruitment business globally, Apsida Insights covers it all. Whether you're a life science professional, hiring manager or recruiter, tune in for expert insights and inspiration to stay ahead.
Stay informed. Stay inspired. Stay ahead.
In this episode CCO Ben Pearce (https://www.linkedin.com/in/benpearce7/), sits down with VP of North America Jon Orsbourn (https://www.linkedin.com/in/jon-orsbourn-654364105/) as he shares his journey from London to Boston, stepping into the US recruitment market while staying true to Apsida’s mission.
Jon opens up about the challenges and opportunities of transitioning to the US, both professionally and personally.
From adapting to a new business landscape to embedding himself in Boston’s thriving life sciences scene, he gives us an inside look at his experience so far.
We’ll also dive into what’s next for Apsida in Boston, the company’s expansion plans, and how Jon is shaping the future of our business in the US.
If you’re interested in career growth, market expansion, or what it takes to make an impact in a new city, this is an episode you don’t want to miss!
17 Jan 2025
London Calling | The Future of Apsida Life Science
Senior Director Harry Williams (https://www.linkedin.com/in/harry-williams-068ba213a/) joins Chief Commercial Officer Michael Georgiadis (https://www.linkedin.com/in/michael-georgiadis-b11063b1/) to discuss the bold launch of Apsida’s London office.
They explore the vision behind the expansion, what makes London the perfect next step for Apsida, and how this new chapter sets the stage for exciting growth in 2025 and beyond.
Harry shares his passion for building a culture of trust, innovation, and elite performance while offering insight into what it takes to create a thriving recruitment hub.
Whether you’re curious about Apsida’s journey or considering joining the London team, this episode is a must-listen!
19 Dec 2024
The Sofa | From 'The Boom' to Breakthrough
Co-founders Ben (https://www.linkedin.com/in/benpearce7/), Jamie (https://www.linkedin.com/in/jamie-salmon-608501a9/), and Michael (https://www.linkedin.com/in/michael-georgiadis-b11063b1/) reflect on the pivotal moments that shaped 2024—and how these experiences are setting the stage for an even bigger 2025.
Join us for our first ‘Sofa Session’ as they discuss:
• Lessons learned from the Covid boom and beyond.
• The importance of culture, celebrating wins, and adapting to change.
• How the London and Boston expansions are just the start of what’s to come.
And this is only the beginning—future episodes take a closer, more personal look at Apsida’s journey. This series offers a deeper insight into the people, the passion, and the plans shaping Apsida’s future.
24 Sept 2024
Targeted Talks: Leaders in Oncology - Behzad Kharabi
In our latest episode, Jamie Salmon (https://www.linkedin.com/in/jamie-salmon-608501a9/) sits down with the brilliant Behzad Kharabi (https://www.linkedin.com/in/behzadkharabi/), a leader who's transformed the oncology space.
From an aspiring doctor to becoming a Chief Medical Officer with a global impact, Behzad's journey is nothing short of inspiring.
In this episode, he shares the career-defining feedback that steered him from academia into industry, how he's navigated the challenges of leadership, and his powerful advice for the next generation of CMOs.
Read our Key Takeaways from the episode here (https://apsida.co.uk/targeted-talks-behzad-kharabi-aspiring-doctor-turned-global-oncology-cmo/).
5 Sept 2024
Targeted Talks: Leaders in Oncology - Eliel Bayever
Welcome to the third instalment of Targeted Talks, in which our Co-Founder and Director, Jamie Salmon (https://uk.linkedin.com/in/jamie-salmon-608501a9), sits down with world-class oncology leaders to hear about their journeys so far.
In this edition, Eliel Bayever (https://www.linkedin.com/in/eliel-bayever-413a55b/) shares his story of being a well-respected paediatric clinician and diving head-first into the pharmaceutical industry much later than many of his peers.
In our latest blog post (https://apsida.co.uk/targeted-talks-a-paediatricians-climb-to-becoming-chief-medical-officer/), we’ll highlight some of the key takeaways from Jamie’s conversation with Eliel.
5 Aug 2024
Targeted Talks: Leaders in Oncology - Elisabeth Oelmann
Targeted Talks | Apsida’s Co-Founder and Director, Jamie Salmon (https://www.linkedin.com/in/jamie-salmon-608501a9/), sits down with world-class oncology leaders to hear about their journeys so far. In this month's episode, Elisabeth Oelmann (https://www.linkedin.com/in/elisabeth-oelmann-md-phd-6a492125/) shares her inspiring story from being a ‘naive’ teenager in Germany to becoming an SVP oncology leader in the United Kingdom. During the conversation, Elisabeth highlights the secret to successfully managing a global remote team, what it’s really like to move from big pharma to small biotech, and more!Read our key takeaways (https://apsida.co.uk/elisabeth-oelmann-naive-teenager-to-svp-oncology-leader/) from the episode.
1 Aug 2024
Bonus Episode | Should Biotechs allow physicians to continue clinical practice?
Apsida's Co-Founder Jamie Salmon (https://www.linkedin.com/in/jamie-salmon-608501a9/), and Dr. Michael Grant (https://www.linkedin.com/in/drmichaelgrant/)(Executive Medical Director at Infinitropes) explore the mutual benefits of industry-based physicians maintaining a clinical practice. In our latest blog post (https://apsida.co.uk/why-biotechs-should-allow-physicians-to-continue-clinical-practice/), we also offer advice for biotechs keen to support physicians in this dual role and industry-based physicians aiming to continue their clinical practice.
5 Jul 2024
Targeted Talks: Leaders in Oncology - Dr. Michael Grant
Welcome to the first instalment of Targeted Talks, Apsida’s (https://apsida.co.uk)newest podcast and blog series in which our Co-Founder and Director, Jamie Salmon (https://uk.linkedin.com/in/jamie-salmon-608501a9), sits down with world-class oncology leaders to hear about their journeys so far.
In this edition, Dr Michael Grant (https://uk.linkedin.com/in/drmichaelgrant) shares his impressive story of following a traditional academic career before unexpectedly transitioning to the biotech industry.
View our key takeaways from the episode here (https://apsida.co.uk/targeted-talks-an-oncologists-journey-from-academia-to-industry/), where we provide relevant links from the episode.
Faculty of Pharmaceutical Medicine guide (https://www.fpm.org.uk/our-specialty/careers/)
20 Jun 2024
Introducing Target Talks: Leaders in Oncology
With 10 years of experience and connections in the Oncology Clinical Development field, Jamie Salmon (https://www.linkedin.com/in/jamie-salmon-608501a9/) brings you inspiring stories and invaluable insights from industry leaders, in our latest Apsida Insights segment.
Discover the unique career paths that led these pioneers to oncology, the passions that drive them, and their visions for the future.
Get a glimpse into the human side of leadership, from team-building strategies to personal advice for aspiring professionals.
Tune in to be inspired, informed, and empowered to make your impact in the world of Oncology.
29 Apr 2024
Diversifying Leadership | Sarah McKeown-Cannon, Publicis Health
Our next guest is Sarah McKeown-Cannon (https://www.linkedin.com/in/sarah-mckeown-cannon-0a739b76/), who is the VP of Growth for Publicis Health and an expert in Clinical Trial Experience. As a rare disease patient herself, Sarah’s passion for human-centred research is personal. She challenges clients to think beyond the boundaries of “traditional” clinical trial design to solve their number one challenge - patient recruitment - by recognising patients as individuals and building truly inclusive clinical trials.
Her leadership journey is inspiring, and we’re sure you’ll enjoy this episode just as much as we did.
Read our key takeaways from this episode: https://apsida.co.uk/leadership/diversifying-leadership-sarah-mckeown-cannon/ (https://apsida.co.uk/leadership/diversifying-leadership-sarah-mckeown-cannon/)
11 Apr 2024
Diversifying Leadership | Jane Myles, DTRA
Our second guest is Jane Myles, who is the Program Director for the DTRA and advisor to several life sciences organizations. Her career, spanning over two and a half decades, has seen her work for some of the most well-known and respected organisations in the world. We would love to hear your feedback on the series and if you have any questions/ topics you would like us to discuss in future episodes then comment below.To read our key takeaways from the episode, follow the link here: https://apsida.co.uk/leadership/diversifying-leadership-jane-myles/ (https://apsida.co.uk/leadership/diversifying-leadership-jane-myles/)
11 Apr 2024
Diversifying Leadership | Dawn Brockett, CNS Summit
Our host for this series is William Penticost, who is Head of Vendor Services at Apsida Life Science.
We're kicking off 2024 with Dawn Brockett who is an author, keynote speaker, professor, advisor in the research and treatment of anorexia, and the managing director of CNS Summit.
We would love to hear your feedback on our first episode and if you have any questions/ topics you would like us to discuss in future episodes then comment below.
To read our key takeaways from the episode, follow the link below: https://apsida.co.uk/leadership/diversifying-leadership-dawn-brockett/ (https://apsida.co.uk/leadership/diversifying-leadership-dawn-brockett/)
Reach and audience
Public platform figures. Ratings count people who left a rating, not total listeners.
YouTube views
1,342
Score snapshot 15 Sept 2025
Podcast Authority Score: 31 / 100
A composite of feed quality, social presence, YouTube performance and engagement. Read the methodology.
Quality
36
Social presence
0
YouTube
68
Engagement
0
Host of Apsida Insights?
Claim your podcast to manage its listing and keep your show details accurate.
Pod Engine is an independent podcast discovery and analytics service and is not affiliated with or endorsed by this podcast. Artwork and show content belong to their owners. Full legal notice.
Explore this show Podcast research with Pod Engine
